Search Results

240 results for COV

CEMI Stock: $28M Covid Test Order Sends Chembio Diagnostics Skyrocketing

CEMI stock is soaring after inking its first multi-million dollar sales contract for its FDA-approved Covid-19 rapid antigen test.

3 Medical Device Companies for a Healthy Portfolio

These three companies have significant upside, strong fundamentals and are well positioned to take advantage of growth in this increasingly profitable niche.

The Bear Market Double Whammy

Bear markets can slam your portfolio twice if you’re not careful. You already know that a bear market can whack your portfolio on its way…

5 Medical Devices Stocks to Buy Now

This week, five Medical Devices stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or…

Why Is Tonix Pharmaceuticals (TNXP) Stock Up 40% Today?

TNXP stock traders are in a bidding war today as Tonix announces a possible game-changer in Covid-19 treatment methodologies.

Biggest Movers in Healthcare Stocks Now – CLDX ALGN WST PDCO

Healthcare stocks declined on Wall Street on Wednesday, down 0.1%.

Biggest Movers in Healthcare Stocks Now – MNKD CLDX NPSP ACAD

Healthcare stocks fell on Wall Street so far on Wednesday, down 1.2%.

Biggest Movers in Healthcare Stocks Now – LCI STJ CYH SIRO

Healthcare stocks rose 0.5% on Wall Street today.

Hottest Healthcare Stocks Now – ACOR SHPG WX ACT

Healthcare stocks remained flat on Wednesday morning on Wall Street.

Hottest Healthcare Stocks Now – RDY ABBV SPNC UHS

Healthcare stocks declined broadly on Wall Street on Thursday, with the sector seeing an overall decline of 1.3%.

Hottest Healthcare Stocks Now – ISRG CAH MRK LH

Healthcare stocks finished up broadly on Wall Street on Thursday, with the sector seeing an overall increase of 0.8%.

The Beginner’s Roadmap to Investing in AGI

Eric Fry has developed a three-step process for finding companies that will survive and thrive on The Road to AGI.

15 Companies Increasing Dividends

A number of solid blue chips, including Microsoft and McDonald’s, led this week’s list of dividend-boosting stocks.

NNVC Stock: What Is Going on With Red-Hot NanoViricides Today?

A Covid-19 treatment producer halted trading this morning, but news has revealed that NNVC stock is still moving upward.

Why Is LumiraDx (LMDX) Stock Up 30% Today?

LumiraDx (LMDX) stock is heading higher on Wednesday morning after the company received approval for its Covid and RSV tests.

8 Healthcare Stocks to Sell

To keep you from getting into the wrong healthcare care companies or sticking with some sickly stocks, here’s my list of 8 big-name medical companies…

7 Software Stocks to Sell Now

This week, the overall grades of seven software stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…

8 Software Stocks to Sell Now

This week, 8 Software stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

FedEx Flies, Discover Dives — Thursday’s IP Market Recap

Both beat earnings estimates, but then went separate ways.

Target Highly Promising Antiviral Therapeutics with Cocrystal Pharma

A buying opportunity is here as COCP stock is down, even as Cocrystal makes progress in developing a potentially lifesaving antiviral drug.

7 Medical Devices Stocks to Buy Now

The grades of seven Medical Devices stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong…

Hold Merck for Its Solid Dividend and Covid-19 Treatment Prospects

MRK stock might not be an obvious “vaccine stock,” but Merck’s commitment to combating Covid-19 is commendable and potentially profitable.

Windows of Opportunity Are Tightening for Sorrento Therapeutics

Thanks to Sorrento Therapeutics’ all-out pivot to address the Covid-19 pandemic, SRNE stock initially became one of the most popular investments. But as both the…

9 Software Stocks to Sell Now

This week, 9 Software stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

4 – 10 of 240 results